This Hidden Health Care Cost Keeps Heading Higher
8 Ways to Save for the Holidays in the Next 8 Weeks
Toxic Chemicals Taint Many Halloween Costumes, Products
4 Chinese Internet Stocks That Are Better Bets Than Alibaba
Johnson & Johnson Launches Offer for Crucell
Giant drugmaker Johnson & Johnson has agreed to buy Dutch vaccine maker Crucell. The deal will give J&J a bigger piece of the vaccine market and better access to emerging markets.
Still in hot water over its "phantom recall" of a Motrin product, Johnson & Johnson looks to expand its share of the vaccine market with purchase of Dutch pharma company Crucell.
Novavax (NVAX) shares soared some 10 percent today after the small clinical-stage biotechnology company announced positive preclinical results for...